Owlstone Medical Secures Funding To Develop Its Breath Biopsy Technology
The oversubscribed $58m funding round will enable the company to further work on its first-in-class breath biopsy technology, which aims to provide a cheap and convenient screening tool for several diseases.
You may also be interested in...
Following a successful fundraise, Angle is poised to further commercialize its proprietary cell-catching technology for cancer diagnosis
Results showed that patients were less likely to exhibit disease progression, or die, following treatment with beta-emitted microspheres.
A pilot study of the augmented reality system suggests it improves the precision of knee arthroplasty surgery.